Surgical Site Infections Clinical Trials

9 recruiting

Surgical Site Infections Trials at a Glance

7 actively recruiting trials for surgical site infections are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Bangkok, Bordeaux, and Brandon. Lead sponsors running surgical site infections studies include Ondine Biomedical Inc., National and Kapodistrian University of Athens, and Siriraj Hospital.

Browse surgical site infections trials by phase

About Surgical Site Infections Clinical Trials

Looking for clinical trials for Surgical Site Infections? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Surgical Site Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Surgical Site Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Surgical Site Infections
Ondine Biomedical Inc.4,514 enrolled14 locationsNCT06702878
Recruiting
Not Applicable

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada

InfectionsSurgical Site InfectionsSurgical Wound Infections+1 more
Ondine Biomedical Inc.4,740 enrolled4 locationsNCT07189858
Recruiting
Not Applicable

Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages

CABGCoronary Artery Bypass GraftDelayed Wound Healing+6 more
Siriraj Hospital106 enrolled2 locationsNCT06603961
Recruiting
Not Applicable

Incidence of Depression and Its Complications After Surgical Site Infection - ISODEP.

DepressionMalnutritionSurgical Site Infections
University Hospital, Bordeaux300 enrolled1 locationNCT07125196
Recruiting

Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients

Surgical Site InfectionsStaphylococcus Aureus Colonization
University of Minnesota250 enrolled1 locationNCT06378359
Recruiting
Not Applicable

NoPro - Norwegian Hernia Prophylaxis Study

Quality of Life (QOL)Surgical Site InfectionsIncisional Hernia After Midline Laparotomy+1 more
Sykehuset Innlandet HF150 enrolled1 locationNCT06858020
Recruiting
Not Applicable

Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients

Gynecological CancerSurgical Site InfectionsSupplemental Oxygen
National and Kapodistrian University of Athens400 enrolled1 locationNCT06780813